← Evidence map

ArticleThe Prostate2026

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.

Atsushi Mizokami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study. | OpenQuestion